CLOV is trading at $5.46 (4.1% up), extending its recent upside momentum following a strong performance throughout 2026.
- Investors continue to react to fundamental drivers, including robust revenue growth and a recent CMS rating upgrade.
- The move appears to be stock-specific, as the gains come while broader markets remain mixed.
- The stock is building on a significant multi-year run, maintaining positive sentiment among market participants.